
Welcure Pharmaceuticals Private Limited
About Welcure Pharmaceuticals Private Limited
Data last updated:
Welcure Pharmaceuticals Private Limited was a private limited company based in New Delhi, Delhi, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 21 August 1986.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1986PTC025186.
The company had an authorised share capital of ₹30 Lakh and a paid-up capital of ₹25.3 Lakh. It was led by directors Sanjeev Jain and Sandeep Jain.
Its last annual general meeting (AGM) was held on 04 May 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office was at Office No. 301 3rd Floor Laxmi Tower Lsc Saraswati Vihar Pitampura, New Delhi, Delhi, India – 110034.
As per the financials filed for FY 2024, the company reported a revenue of ₹6.93 Lakh, a growth of 52% compared to the previous year. For the same year it recorded a net profit of ₹5.08 Lakh (net margin 73.2%) and EBITDA of ₹6.78 Lakh (EBITDA margin 97.8%). Revenue has declined at a compounded annual rate (CAGR) of 9% over three years and 37% over five years.
Company details
Contact details
Welcure Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressOffice No. 301 3rd Floor Laxmi Tower Lsc Saraswati Vihar Pitampura, New Delhi, Delhi, India – 110034
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Welcure Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Welcure Pharmaceuticals Private Limited
FY 2024 filings availableWelcure Pharmaceuticals Private Limited reported revenue of ₹6.93 Lakh (up 52% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 52% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 37%. EBITDA rose 324% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.78 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.08 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 97.8% | ||||
| Net Profit Margin | 73.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Welcure Pharmaceuticals Private Limited, buy the company report.
Board of directors of Welcure Pharmaceuticals Private Limited
Welcure Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjeev Jain Also directs: Akums Drugs and Pharmaceuticals Limited | Director | 21 Aug 1986 | 40 Years 2 Months | As last reported |
| Sandeep Jain Also directs: Akums Drugs and Pharmaceuticals Limited | Director | 04 Oct 1999 | 27 Years 1 Months | As last reported |
Auditor
Welcure Pharmaceuticals Private Limited is audited by Vibhor Gupta & Associates for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Vibhor Gupta & Associates | FY 2022 | 512698 |
Shareholding
The shareholding of Welcure Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Welcure Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Welcure Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Welcure Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Welcure Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Welcure Pharmaceuticals Private Limited has 2 board changes on record since 1986: 2 appointments. The latest: Sandeep Jain was appointed as Director on 04 Oct 1999.
Frequently asked questions
Welcure Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Welcure Pharmaceuticals was a private limited company based in New Delhi, Delhi, India. The company worked in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 21 August 1986 and is registered under CIN U74899DL1986PTC025186. The company has been struck off by the Registrar of Companies and is no longer operational.
Welcure Pharmaceuticals had 2 directors:
- Sanjeev Jain - Director
- Sandeep Jain - Director
The CIN (Corporate Identification Number) of Welcure Pharmaceuticals is U74899DL1986PTC025186. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Welcure Pharmaceuticals is at Office No. 301 3rd Floor Laxmi Tower Lsc Saraswati Vihar Pitampura, New Delhi, Delhi, India – 110034.
Welcure Pharmaceuticals was incorporated on 21 August 1986. It is registered with the Registrar of Companies, Delhi.
The latest financial statements of Welcure Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 04 May 2024. Year-wise statements from 2015 are in the company report.
Welcure Pharmaceuticals operated in the pharma industry, in the pharmaceutical retailers and distributors segment. It worked in this industry before it was struck off.
Sandeep Jain was appointed as Director on 04 Oct 1999. Sanjeev Jain was appointed as Director on 21 Aug 1986.
The compliance status of Welcure Pharmaceuticals is compliant as of 28 September 2026.

